Literature DB >> 18330456

Implication of the polyamine system in mental disorders.

Laura M Fiori1, Gustavo Turecki.   

Abstract

The polyamine pathway has an essential role in many cellular functions and has been implicated in several pathological conditions. Accumulating evidence suggests that the polyamine system also plays a role in the etiology and pathology of mental disorders. Alterations in the expression and activity of polyamine metabolic enzymes, as well as changes in the levels of the individual polyamines, have been observed in multiple conditions, including schizophrenia, mood disorders, anxiety and suicidal behaviour. Additionally, these components have been found to be altered by various psychiatric treatments. Further, the polyamines and their precursors have demonstrated both antidepressant and anxiolytic effects. Overall, findings to date suggest that the polyamine pathway represents an important frontier for the development of neuropharmacological treatments.

Entities:  

Keywords:  depression; mental disorders; polyamines; schizophrenia; stress; suicide

Mesh:

Substances:

Year:  2008        PMID: 18330456      PMCID: PMC2265312     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  92 in total

1.  Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.

Authors:  Mariana P Zeidan; Andréa D E Zomkowski; Angelo O Rosa; Ana Lúcia S Rodrigues; Nelson H Gabilan
Journal:  Eur J Pharmacol       Date:  2007-03-24       Impact factor: 4.432

2.  Polyamine metabolism and function in brain.

Authors:  N Seiler
Journal:  Neurochem Int       Date:  1981       Impact factor: 3.921

3.  A central role for the polyamines in the aetiology of schizophrenia.

Authors:  R C Richardson-Andrews
Journal:  Med Hypotheses       Date:  1983-06       Impact factor: 1.538

4.  Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice.

Authors:  Andrea D E Zomkowski; Adair Roberto S Santos; Ana Lúcia S Rodrigues
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-07-05       Impact factor: 5.067

Review 5.  Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.

Authors:  David Mischoulon; Maurizio Fava
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

6.  Plasma agmatine and platelet imidazoline receptors in depression.

Authors:  A Halaris; H Zhu; Y Feng; J E Piletz
Journal:  Ann N Y Acad Sci       Date:  1999-06-21       Impact factor: 5.691

Review 7.  S-adenosylmethionine (SAMe) as treatment for depression: a systematic review.

Authors:  Anna-leila Williams; Christine Girard; Danny Jui; Alyse Sabina; David L Katz
Journal:  Clin Invest Med       Date:  2005-06       Impact factor: 0.825

Review 8.  Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival.

Authors:  Gad M Gilad; Varda H Gilad
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

9.  Limited blood-brain barrier transport of polyamines.

Authors:  W W Shin; W F Fong; S F Pang; P C Wong
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

10.  The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation.

Authors:  V H Gilad; J M Rabey; Y Kimiagar; G M Gilad
Journal:  Biochem Pharmacol       Date:  2001-01-15       Impact factor: 5.858

View more
  27 in total

Review 1.  Suicide and the polyamine system.

Authors:  Jeffrey A Gross; Gustavo Turecki
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-11       Impact factor: 4.388

2.  Polyamines and suicide risk.

Authors:  G Turecki
Journal:  Mol Psychiatry       Date:  2013-10-29       Impact factor: 15.992

3.  Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.

Authors:  Gary Gang Chen; Laura M Fiori; Luc Moquin; Alain Gratton; Orval Mamer; Naguib Mechawar; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

Review 4.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

Review 5.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

6.  Epigenetics and suicidal behavior research pathways.

Authors:  Gustavo Turecki
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

7.  The Role of Epigenetic Dysregulation in Suicidal Behaviors.

Authors:  Laura M Fiori; Gustavo Turecki
Journal:  Curr Top Behav Neurosci       Date:  2020

Review 8.  Understanding epigenetic architecture of suicide neurobiology: A critical perspective.

Authors:  Bhaskar Roy; Yogesh Dwivedi
Journal:  Neurosci Biobehav Rev       Date:  2016-11-09       Impact factor: 8.989

9.  Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide.

Authors:  Laura M Fiori; Brigitte Wanner; Valérie Jomphe; Jordie Croteau; Frank Vitaro; Richard E Tremblay; Alexandre Bureau; Gustavo Turecki
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide.

Authors:  Jeffrey A Gross; Laura M Fiori; Benoit Labonté; Juan Pablo Lopez; Gustavo Turecki
Journal:  J Psychiatr Res       Date:  2012-12-20       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.